BDBM458278 US10752616, Code No. BHBA-036

SMILES Cc1ccc(C)c2oc(cc12)-c1nnc(o1)-c1ccc(cc1Cl)C(O)=O

InChI Key InChIKey=FRZGIDLPTLULST-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 458278   

TargetRetinoic acid receptor beta(Human)
King''S College London

US Patent
LigandPNGBDBM458278(US10752616, Code No. BHBA-036)
Affinity DataEC50:  28nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor gamma(Human)
King''S College London

US Patent
LigandPNGBDBM458278(US10752616, Code No. BHBA-036)
Affinity DataEC50:  58nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
King''S College London

US Patent
LigandPNGBDBM458278(US10752616, Code No. BHBA-036)
Affinity DataEC50:  225nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent